1. Home
  2. FNWD vs TNYA Comparison

FNWD vs TNYA Comparison

Compare FNWD & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$36.18

Market Cap

164.2M

Sector

Finance

ML Signal

N/A

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
TNYA
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.2M
178.5M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
FNWD
TNYA
Price
$36.18
$0.68
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$37.50
$5.33
AVG Volume (30 Days)
4.6K
5.0M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
54.96
EPS
1.88
N/A
Revenue
N/A
N/A
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
$1,456.12
P/E Ratio
$19.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.46
$0.36
52 Week High
$39.99
$2.35

Technical Indicators

Market Signals
Indicator
FNWD
TNYA
Relative Strength Index (RSI) 45.32 43.92
Support Level $35.25 $0.66
Resistance Level $38.79 $0.70
Average True Range (ATR) 0.74 0.06
MACD -0.16 -0.02
Stochastic Oscillator 26.81 21.90

Price Performance

Historical Comparison
FNWD
TNYA

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: